Tagdulang, Cresencia F.
HRN: 24-88-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/21/2024
04/28/2024
IV
600mg
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes